Global Hypoparathyroidism Treatment Industry is set to achieve a valuation of US$ 1,767.4 Million by 2033, influenced by a commitment to Patient-Centered Care | FMI
The global hypoparathyroidism treatment industry is on the brink of substantial growth, as revealed by